🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.

Regeneron Pharmaceuticals, Inc. vs The Sherwin-Williams Company

Market cap comparison over time

Regeneron Pharmaceuticals, Inc.

$79.7B

Rank #191

The Sherwin-Williams Company

$79.9B

Rank #189

Market Cap Over Time

Key Moments

  • Regeneron Pharmaceuticals, Inc. overtook The Sherwin-Williams Company by 1995
  • The Sherwin-Williams Company overtook Regeneron Pharmaceuticals, Inc. by 1997
  • Regeneron Pharmaceuticals, Inc. overtook The Sherwin-Williams Company by 1999
  • The Sherwin-Williams Company overtook Regeneron Pharmaceuticals, Inc. by 2003
  • Regeneron Pharmaceuticals, Inc. overtook The Sherwin-Williams Company by 2012
  • The Sherwin-Williams Company overtook Regeneron Pharmaceuticals, Inc. by 2019
  • Regeneron Pharmaceuticals, Inc. overtook The Sherwin-Williams Company by 2022
  • The Sherwin-Williams Company overtook Regeneron Pharmaceuticals, Inc. by 2024

Year-by-Year Comparison

YearRegeneron Pharmaceuticals, Inc.The Sherwin-Williams CompanyLeader
2026$79.7B$79.9BThe Sherwin-Williams Company
2025$79.3B$79.5BThe Sherwin-Williams Company
2024$72.8B$82.7BThe Sherwin-Williams Company
2023$89.7B$75.3BRegeneron Pharmaceuticals, Inc.
2022$73.7B$56.7BRegeneron Pharmaceuticals, Inc.
2021$64.5B$83.3BThe Sherwin-Williams Company
2020$49.4B$57.5BThe Sherwin-Williams Company
2019$38.4B$45.3BThe Sherwin-Williams Company
2018$38.2B$30.2BRegeneron Pharmaceuticals, Inc.
2017$38.4B$31.2BRegeneron Pharmaceuticals, Inc.
2016$37.5B$20.3BRegeneron Pharmaceuticals, Inc.
2015$55.5B$19.3BRegeneron Pharmaceuticals, Inc.
2014$41.9B$19.4BRegeneron Pharmaceuticals, Inc.
2013$28.1B$13.4BRegeneron Pharmaceuticals, Inc.
2012$17.5B$11.1BRegeneron Pharmaceuticals, Inc.
2011$5.7B$6.4BThe Sherwin-Williams Company
2010$3.4B$5.9BThe Sherwin-Williams Company
2009$2.5B$4.2BThe Sherwin-Williams Company
2008$1.9B$4.0BThe Sherwin-Williams Company
2007$2.5B$3.8BThe Sherwin-Williams Company
2006$2.1B$4.1BThe Sherwin-Williams Company
2005$1.6B$2.9BThe Sherwin-Williams Company
2004$941.1M$2.7BThe Sherwin-Williams Company
2003$1.5B$2.1BThe Sherwin-Williams Company
2002$1.9B$1.7BRegeneron Pharmaceuticals, Inc.
2001$2.9B$1.6BRegeneron Pharmaceuticals, Inc.
2000$3.6B$1.5BRegeneron Pharmaceuticals, Inc.
1999$1.3B$1.2BRegeneron Pharmaceuticals, Inc.
1998$753.6M$1.6BThe Sherwin-Williams Company
1997$874.9M$1.5BThe Sherwin-Williams Company
1996$1.6B$1.5BRegeneron Pharmaceuticals, Inc.
1995$1.3B$1.1BRegeneron Pharmaceuticals, Inc.
1994$306.5M$850.4MThe Sherwin-Williams Company